Overview
Safety in plain terms
Generally tolerated; bleeding and drug interaction discussions at higher doses.
Tolerability
Commonly reported effects
- GI upset
Higher-risk contexts
Who should pause or get medical guidance first
- People on anticoagulants without clinician coordination
Polypharmacy
Interactions & cautions
- Anticoagulants
- CYP substrates (discussion)
Practical
Dose context (not a prescription)
Bioavailability challenges drive formulation wars; labels rarely translate to trial equivalence.
Our editorial safety score is 74/100 - methodology and limitations are on the full hub page.
Verdict context
Studies conflict or are small; some plausible benefits, but the signal is too noisy for strong claims.
Same ingredient, other questions
Focused pages for common searches about Resveratrol. Each uses the same underlying evidence file with a different lens.
Explore further
A few hand-picked entry points around Resveratrol: categories, answers to narrow questions, and comparisons.
Category hubs
Focused questions
Related ingredients
Ingredients we group near Resveratrol in our model - not interchangeable, but often read together.
- NMN (nicotinamide mononucleotide)52/100Mixed evidence
NAD+ precursor marketed for aging; human trials are growing but long-term outcomes remain unproven and regulatory status has been messy.
- Psyllium husk78/100Strong support
Soluble fiber with strong evidence for constipation and as a lipid adjunct in some guideline discussions when taken with water.
- Omega-3 fatty acids77/100Promising
EPA/DHA support cardiovascular risk reduction contexts in some guidelines; supplements vary widely in quality and dose.
Alternatives
Swaps people discuss alongside Resveratrol - still judge each ingredient on its own evidence.